DKCM
IDXX icon

Davidson Kempner Capital Management’s Idexx Laboratories IDXX Stock Holding History

Davidson Kempner Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,000
Closed -$5.05M – 534
2021
Q2 		$5.05M Buy
+8,000
New +$4.42M 0.04% 228

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Davidson Kempner Capital Management's IDXX Position: Q3 2021 in Review

Davidson Kempner Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 8,000 shares — an estimated $5.05M sold.

Davidson Kempner Capital Management first reported a position in IDXX in Q2 2021 and held it in 1 quarter. The position peaked at $5.05M in Q2 2021. 1,058 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Davidson Kempner Capital Management reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 8,000 Idexx Laboratories shares in Q3 2021, an estimated $5.05M.
  • Davidson Kempner Capital Management first reported a position in Idexx Laboratories in Q2 2021 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Idexx Laboratories position peaked at $5.05M in Q2 2021.
  • 1,058 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.